logo

For the Inventor, By the Inventor

Los Altos, CA, United States of America

Ving J Lee

This inventor holds 33 USPTO granted patents and 7 published patent applications, primarily in Antibiotic Development. Top assignees: Microcide Pharmaceuticals, Inc., Anacor Pharmaceuticals, Inc., Essential Therapeutics, Inc.. Active years: 1997-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ving J Lee. Retrieved from https://idiyas.com/inventor/ving-j-lee-4wzprbqd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 

% Patents Active = 90.9

Average Co-Inventor Count = 5.1

ph-index = 13

Forward Citations = 446(Granted Patents)


Location History:

  • Mountain View, CA (US) (2003)
  • Los Altos, CA (US) (1997 - 2012)

Company Filing History:

goldMedal18 out of 26 
 
Microcide Pharmaceuticals, Inc.
 patents
silverMedal5 out of 70 
 
Anacor Pharmaceuticals, Inc.
 patents
bronzeMedal5 out of 12 
 
Essential Therapeutics, Inc.
 patents
4. 2 out of 12 
 
Iconix Pharmaceuticals, Inc.
 patents
5. 2 out of 113 
 
Wyeth Holdings Corporation
 patents
6. 1 out of 1 
 
Limerick Biopharma
 patent

Years Active: 1997-2012

Loading Chart...
Areas of Expertise:
Antibiotics
Cephalosporin
Efflux Pump Inhibitors
Hydrolytically-resistant
Boron-containing Therapeutics
Peptidomimetics
Bacterial Infection
Rho C Modulators
Staphylococcus Aureus
Beta-lactam
Uridyl Peptide Antibiotic
7-Substituted Amino Tetracyclines
33 patents (USPTO):Explore Patents
1. 8106031 - Hydrolytically-resistant boron-containing therapeutics and methods of use (2012-01-31),
2. 7968752 - Hydrolytically-resistant boron-containing therapeutics and methods of use (2011-06-28),
3. 7947733 - Phosphorylated pyrone analogs and methods (2011-05-24),
4. 7888356 - Antibiotics containing borinic acid complexes and methods of use (2011-02-15),
5. 7465836 - Hydrolytically-resistant boron-containing therapeutics and methods of use (2008-12-16),
6. 7390806 - Antibiotics containing borinic acid complexes and methods of use (2008-06-24),
7. RE40183 - 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines (2008-03-24),
8. RE40086 - Method for treating bacterial infection with novel 7-substituted-9-substituted amino 6-demethyl-6-deoxytetracyclines (2008-02-18),
9. 6723716 - 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof (2004-04-20),
10. 6642263 - Modulators of Rho C activity (2003-11-04),
11. 6638718 - Methods of screening for compounds active on staphylococcus aureus target genes (2003-10-28),
12. 6630303 - Methods of screening for compounds active on Staphylococcus aureus target genes (2003-10-07),
13. 6482921 - Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use (2002-11-19),
14. 6455268 - Hydrolytic enzyme substrates and assay method (2002-09-24),
15. 6436980 - Peptidomimetic efflux pump inhibitors (2002-08-20),

Title: Ving J Lee: Innovator in Boron-Containing Therapeutics

Introduction

Ving J Lee is a notable inventor based in Los Altos, California, renowned for his significant contributions to the field of therapeutics. With an impressive portfolio of 33 patents, his work primarily focuses on innovative compounds and methods intended to combat various diseases.

Latest Patents

Among his latest inventions, Ving J Lee has developed hydrolytically-resistant boron-containing therapeutics. These patents detail the compositions and methods of use for boron derivatives, including benzoxaboroles, benzazaboroles, and benzthiaboroles, as therapeutic agents against diseases caused by fungi, yeast, bacteria, or viruses. Additionally, he has outlined methods for the synthesis of these agents and their compositions, showcasing an advanced understanding of chemical applications in medicine.

Career Highlights

Throughout his career, Ving J Lee has been associated with prominent companies such as Microcide Pharmaceuticals and Anacor Pharmaceuticals. His role in these organizations has enabled him to contribute significantly to drug development and innovative therapeutic solutions.

Collaborations

Ving J Lee has collaborated with distinguished professionals in the pharmaceutical arena, including Zhijia J Zhang and Scott J Hecker. These collaborations have enhanced the scope and impact of his research, leading to groundbreaking developments in therapeutic options.

Conclusion

Ving J Lee's continued innovation in the realm of boron-containing therapeutics positions him as a key figure in modern medicine. His extensive patent portfolio reflects his dedication to developing effective treatments for various pathogens, paving the way for future advancements in pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…